Clinical Trials Directory

Trials / Sponsors / Diffusion Pharmaceuticals Inc

Diffusion Pharmaceuticals Inc

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
TerminatedStudy of Trans Sodium Crocetinate in Patients With Interstitial Lung Disease
Interstitial Lung Disease
Phase 22021-12-02
CompletedRandomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteer
Healthy Volunteers With Induced Hypoxia
Phase 12021-11-09
CompletedSafety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy Volunteers
Healthy Subjects
Phase 12021-03-17
CompletedSafety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected Subjects
SARS-CoV-2 (Covid19)
Phase 1 / Phase 22020-09-10
TerminatedEfficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected Stroke
Stroke, Acute
Phase 22019-08-22
TerminatedSafety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only
Glioblastoma
Phase 32018-01-16
CompletedSafety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Gliob
Glioblastoma, GBM, Glioma
Phase 1 / Phase 22012-02-01
TerminatedTrans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Pa
High Grade Glioma
Phase 12009-03-01
CompletedSafety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermitt
Intermittent Claudication
Phase 1 / Phase 22008-08-01